Skip to content

Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health

Oral Hydrolyzed Keratin Peptide Powder Improves Hair Quality and Scalp Barrier Function: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07458828
Enrollment
120
Registered
2026-03-09
Start date
2024-01-23
Completion date
2025-08-12
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair Damage, Hair Health, Hair Strength

Brief summary

This study is designed to evaluate the efficacy and safety of Hydrolyzed Keratin Peptide Powder in promoting hair health in adult with mild to moderate hair damage, compared to a placebo control.

Interventions

DIETARY_SUPPLEMENTDAP-HAI-403

Each subject takes two capsules per day for 24 weeks. Each capsule contains DAP-HAI-403 250mg.

DIETARY_SUPPLEMENTPlacebo

Each subject takes two capsules per day for 24 weeks.

Sponsors

Dong-A Pharmaceutical
Lead SponsorINDUSTRY
Global Medical Research Center Co., Ltd.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female, aged 19 to 60 years * Subjects with glossy scores between 1 and 3 points on the visual assessment classification and with a total hair damage score of less than 18 points based on exposure to risk factors * Subjects who will refrain from perms or hair coloring, excluding haircuts, during the clinical study period * Subjects who have agreed to participate in this clinical trial prior to its commencement and have signed the written informed consent form

Exclusion criteria

* Subjects with hair loss conditions such as androgenetic alopecia, alopecia areata, telogen effluvium, or cicatricial alopecia at Visit 1 * Subjects who have taken oral dutasteride or finasteride within 6 months prior to Visit 1 * Subjects who have consumed health functional foods (e.g., biotin) or general foods that may affect the human application study within 2 weeks prior to Visit 1 * Subjects who have applied topical steroid preparations to the scalp for one month prior to Visit 1 * Pregnancy or breastfeeding or planning pregnancy

Design outcomes

Primary

MeasureTime frameDescription
The change of hair elasticityChange of the week 24 from baselineElasticity is measured using a Universal Testing Machine (UTM) at a stretching rate of 2 cm/min, and the mean tensile resistance prior to breakage was recorded. A higher score indicates a better outcome.
The change of hair lusterChange of the week 24 from baselineHair luster is evaluated using visual grading (5-point scale), glossymeter (mean value ), and scanning electron microscopy (SEM、 12-point scale ). Both visual grading and glossymeter indicate better outcomes with higher scores. For SEM, lower scores indicate better outcomes.
The change of Self-evaluated satisfactionChange of the week 24 from baselineParticipants assessed their satisfaction of overall changes from baseline across 7 questions, rating perceived satisfaction on a 10-point scale (1 = not at all, 10 = very much).

Secondary

MeasureTime frameDescription
The change of Hair diameterChange of the week 24 from baselineHair diameter is evaluated by phototrichogram device (Folliscope 5.0) at 50× magnification. A higher score indicates a better outcome.
The change of Hair densityChange of the week 24 from baselineHair density is measured using Folliscope 5.0 at 14× magnification. A higher score indicates a better outcome.
The change of Hair root volumeChange of the week 24 from baselineHair root volume was quantified using I Max-plus image analysis software by measuring the angle (°) between the parting's origin and its highest lateral points-smaller angles after treatment indicated improved root lift and volume.
The change of Scalp moistureChange of the week 24 from baselineScalp moisture is measured using the DermaLab Hydration Pin Probe. A higher score indicates a better outcome.
The change of Scalp TEWLChange of the week 24 from baselineScalp TEWL is assessed using a Tewameter TM Nano. A lower score indicates better outcomes.
The change of Self-improvement evaluationWeek 24Participants were asked to complete a self-evaluation questionnaire regarding their overall improvement in the study across 5 questions, rating perceived improvement on a 10-point scale (1 = no improvement, 10 = marked improvement).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026